Idarubicin

Generic name: Idarubicin
Dosage form: intravenous solution (1 mg/mL)
Drug class: Antibiotics / antineoplastics

Usage of Idarubicin

Idarubicin is used in combination chemotherapy in adults to treat acute myeloid leukemia (AML), a type of blood cancer.

Idarubicin may also be used for purposes not listed in this medication guide.

Idarubicin side effects

Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Idarubicin may cause dangerous effects on your heart. Tell doctor right away if you have chest pain, shortness of breath (even with mild exertion), swelling, or rapid weight gain.

Idarubicin may cause serious side effects. Call your doctor at once if you have:

low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;

irritation or skin changes where the injection was given;

pain, blisters, bleeding, or severe rash on the palms of your hands or the soles of your feet;

sores or white patches in or around your mouth; or

severe nausea, vomiting, stomach cramps, or diarrhea.

Common side effects of idarubicin may include:

nausea, vomiting, stomach pain, diarrhea;

mouth sores;

bleeding;

headache;

rash; or

hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Idarubicin

Idarubicin may cause dangerous effects on your heart, especially if you have heart problems, if you have received certain cancer drugs in the past, or if you are over 60.

Tell your doctor if you have ever had:

heart problems;

radiation treatment;

chemotherapy with doxorubicin, Daunorubicin, Epirubicin, idarubicin, or mitoxantrone;

bone marrow suppression;

liver or kidney disease;

gout;

anemia (low red blood cells); or

sepsis (a severe reaction to an infection).

Idarubicin can harm an unborn baby if the mother or the father is using idarubicin.

If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 6.5 months after your last dose.

If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3.5 months after your last dose.

Tell your doctor right away if a pregnancy occurs.

Do not breastfeed while using this medicine, and for at least 14 days after your last dose.

Relate drugs

How to use Idarubicin

Usual Adult Dose for Acute Myeloid Leukemia:

12 mg/m2 daily for 3 days by slow (10 to 15 min) IV administration in combination with cytarabineMaximum recommended cumulative lifetime dose for the IV formulation: 150 mg/m2In patients with unequivocal evidence of leukemia after the first induction course, a second course may be administered.Comment:-Administration of the second course should be delayed in patients who experience severe mucositis until recovery has occurred, and a dose reduction of 25% is recommended. Use: For the treatment of acute myeloid leukemia (AML) in combination with other approved antileukemic drug (including French-American-British [FAB] classifications M1 through M7)

Usual Adult Dose for Acute Nonlymphocytic Leukemia:

Warnings

Idarubicin can increase your risk of bleeding or infection. Call your doctor if you have unusual bruising or bleeding, or new signs of infection (fever, chills, tiredness).

Idarubicin may cause dangerous effects on your heart, especially if you have heart problems, if you have received certain cancer drugs in the past, or if you are over 60.

Seek medical attention right away if you have chest pain, irregular heartbeats, shortness of breath, swelling, or rapid weight gain.

What other drugs will affect Idarubicin

Tell your doctor about all other cancer medicines you have received in the past 7 months, especially:

cyclophosphamide;

paclitaxel; or

trastuzumab.

This list is not complete. Other drugs may affect idarubicin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.